Managing chronic respiratory conditions in primary care
An In-depth Conversation with Dr. Andrew Potter of Whaddon Medical Centre
Pulmonary fibrosis: challenges in diagnosis, treatment and management
Pulmonary fibrosis (PF) is a progressive lung disease characterised by fibrosis or scarring of the lung tissue. As the disease progresses the build-up of fibrotic tissue causes the lungs to stiffen, limiting their ability to expand and contract, resulting in declines in lung function.
Transforming Healthcare Podcast: bridging industry and academia for innovation
In this episode host Dr.
Exploring the complexities of Pulmonary Hypertension
Pulmonary hypertension (PH) is a serious condition characterised by elevated blood pressure within the pulmonary arteries. The pulmonary arteries are responsible for carrying blood from the right-hand side of the heart to the lungs.
Living with paediatric asthma
A number of different management techniques can help in controlling asthma in children. The aim of these management techniques is to enable the child to have a “normal life”, free of asthma symptoms.
Controlling pediatric Asthma symptoms
Asthma, a common childhood respiratory disease involving both airway inflammation and impaired airflow. Asthma places a tremendous pressure on health systems across the globe [1]. It is estimated that one in eleven children in the UK are currently being prescribed treatment for asthma.
Challenges plaguing primary care
An In-depth Conversation with Dr. David Buckley, Trinity Court Surgery
Improving adherence in Asthma treatment
Asthma, a common respiratory disorder affects more than 8 million people in the UK alone [1]. Despite the availability of effective treatments, inhaled corticosteroids (ICS) which are the mainstay of asthma treatment, often show limited efficacy because of suboptimal patient adherence.
Understanding and managing Interstitial Lung Disease
Interstitial lung disease (ILD) is an umbrella term used to describe a group of highly variable restrictive lung diseases, which are characterised by inflammation and pulmonary fibrosis (scarring of the lungs).
Digital Biomarkers: capturing real-world patient journeys to advance care
Digital biomarkers hold great promise in advancing patient care through improved patient monitoring.
Transforming Healthcare: The Future of Cardiovascular Treatments Across the World
In this episode of Transforming Healthcare, host Jay Evans and Dr Bipin Patel are joined by Ami Bhatt, MD.
The future of cardiovascular treatments across the world
In this episode of Transforming Healthcare, host Jay Evans and Dr Bipin Patel are joined by Ami Bhatt, MD.
Realising the potential of digital biomarkers in respiratory care
As healthcare progresses into the digital age, digital biomarkers offer tremendous potential for transforming and improving outcomes in respiratory care, particularly for conditions such as COPD and asthma [1].
Transforming Healthcare Podcast: The importance of collaboration and cooperation in healthcare
In this episode, Dr Bipin Patel reunites with Tony Jones, Chief Executive of One Nucleus, a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge.
Transforming Healthcare Podcast: CES and the opportunities for the medical and health technology sector
In this episode, host, Jay Evans is joined by Dr Bipin Patel and a special guest for this podcast, Karla Pequenino, a journalist at Publico in Portugal.
electronRx to unveil Lung and Heart Digital Monitoring Smartphone Tech at CES 2024
Cambridge-based health tech innovator electronRx is today announcing plans to unveil patient health monitoring smartphone technology at CES 2024, Las Vegas in January. The company will unveil foneDx, a scalable monitoring solution for pulmonary and cardiovascular health using senNew podcast looks at the future of digital healthcare
Transforming Healthcare, the newest podcast series looking into the healthcare sector in the UK and globally, launches to international audiences on all major platforms later this month.
New health technology will protect self-driving car manufacturers
electronRx Limited writes...
How safe will driverless car technology be by 2025?
The government aims to have driverless, or autonomous, cars on the road by 2025.
Cambridge-based electronRx to attend CES® 2024 in Las Vegas
Cambridge-based health tech innovator electronRx is attending the Consumer Technology Association event, CES® in Las Vegas in January 2024 The company will showcase its innovative technology that will revolutionise patient long-term and chronic condition management and understandUndiagnosed breathing conditions could cause winter NHS crisis
electronRx writes...
electronRx shares views on lack of health research hindering public support for clean air schemes
The recent extension of the London ULEZ zone has been contentious with much public backlash to its introduction earlier this year.
The public see this as a direct impact to them as opposed to understanding the benefits to their ongoing health and wellbeing.
electronRx's insights on sleep deprivation
Sleep deprivation is a state caused by a lack of sleep or poor quality of sleep. According to a recent survey of UK workers, only a third reported getting the recommended 7 to 9 hours of sleep per night while almost three-quarters reported having poor sleep quality [1].
Apple leaves door open for android to lead the way on innovation
electronRx writes...Apple announced the launch of the iPhone 15 on 12th September to worldwide fanfare. The manufacturer hailed the new mobile phone as a ‘huge leap forward’ for the brand, with new attractive design features, including colour, contoured edges, and colour-infused black glass.